Item 4. MINE SAFETY DISCLOSURES
5K characters. Original on sec.gov · Markdown
Item 4. MINE SAFETY DISCLOSURES
Not applicable.
INFORMATION ABOUT OUR EXECUTIVE OFFICERS
Set forth below are the names, ages, positions and experience of Danaher’s executive officers as of February 3, 2025. All of Danaher’s executive officers hold office at the pleasure of Danaher’s Board of Directors. Unless otherwise stated, the positions indicated are Danaher positions.
| Name | Age | Position | Officer Since | |||||||||||||||||
| Steven M. Rales | 73 | Chairman of the Board | 1984 | |||||||||||||||||
| Mitchell P. Rales | 68 | Chairman of the Executive Committee | 1984 | |||||||||||||||||
| Rainer M. Blair | 60 | President and Chief Executive Officer | 2014 | |||||||||||||||||
| Matthew R. McGrew | 52 | Executive Vice President and Chief Financial Officer | 2019 | |||||||||||||||||
| Christopher P. Riley | 51 | Executive Vice President | 2024 | |||||||||||||||||
| Julie Sawyer Montgomery | 52 | Executive Vice President | 2024 | |||||||||||||||||
| Georgeann F. Couchara | 48 | Senior Vice President – Human Resources | 2022 | |||||||||||||||||
| Brian W. Ellis | 58 | Senior Vice President – General Counsel | 2016 | |||||||||||||||||
| R. Bradley Gray | 48 | Senior Vice President – Strategic Development | 2024 | |||||||||||||||||
| Jose-Carlos Gutierrez-Ramos | 62 | Senior Vice President – Chief Science Officer | 2020 | |||||||||||||||||
| Daniel A. Raskas | 58 | Senior Vice President – Corporate Development | 2004 |
Steven M. Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Danaher’s Chairman of the Board since 1984. He was also CEO of the Company from 1984 to 1990. Mr. Rales is a brother of Mitchell P. Rales.
Mitchell P. Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Chairman of the Executive Committee of Danaher since 1984. He was also President of the Company from 1984 to 1990. Mr. Rales is also a member of the board of directors of ESAB Corporation, and is a brother of Steven M. Rales.
Rainer M. Blair has served as President and Chief Executive Officer since September 2020, after serving as Executive Vice President from January 2017 to August 2020.
Matthew R. McGrew has served as Executive Vice President and Chief Financial Officer since January 2019.
Christopher P. Riley has served as Executive Vice President since January 2024 after serving as Vice President – Group Executive of Danaher’s Life Sciences subsidiary from July 2022 to December 2023, Vice President-Group Executive of Danaher’s Diagnostics subsidiary from January 2020 to July 2022 and President of Danaher’s Beckman Coulter Diagnostics subsidiary from August 2017 to January 2020.
Julie Sawyer Montgomery has served as Executive Vice President since July 2024 after serving as Vice President – Group Executive of Danaher’s Diagnostics subsidiary from January 2023 to June 2024 and President of Danaher’s Beckman Coulter Diagnostics subsidiary from January 2020 to December 2022.
Georgeann F. Couchara has served as Senior Vice President – Human Resources since April 2022, after serving as Vice President-Talent from January 2021 to April 2022, Vice President – Human Resources for Danaher’s Life Sciences subsidiary from July 2019 to January 2021 and Senior Vice President-Human Resources and Communications for Danaher’s Pall subsidiary from June 2017 to July 2019.
Brian W. Ellis has served as Senior Vice President – General Counsel since joining Danaher in January 2016.
R. Bradley Gray has served as Senior Vice President – Strategic Development since joining Danaher in September 2024. Prior to joining Danaher, Mr. Gray served as President and CEO, and as a member of the board of directors, of NanoString Technologies, Inc., a biotechnology company, from 2010 to May 2024. NanoString filed for bankruptcy in February 2024.
Jose-Carlos Gutierrez-Ramos has served as Senior Vice President – Chief Science Officer since joining Danaher in December 2020. Prior to joining Danaher, Dr. Gutierrez-Ramos served as Vice President – Drug Discovery for AbbVie, Inc., a biopharmaceutical company, from January 2020 to December 2020; and as President and CEO of Repertoire Immune Medicines, a biotechnology company, from August 2018 until January 2020.
Daniel A. Raskas has served as Senior Vice President – Corporate Development since 2010.
PART II
Previous: Item 3. LEGAL PROCEEDINGS · Next: Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES